The number of new coronavirus cases reported on a daily basis has dropped below the 13,000 mark, while other major indicators continue to decrease as well.
Between 5 and 11 December, an average of 12,963 new coronavirus infections were identified every day, down by 23% from the previous seven days, according to figures published by the Sciensano Public Health Institute on Wednesday morning.
The number of tests taken also decreased, by 19% since last week, to 90,136.1. The positivity rate has also dropped slightly and now sits at 16.1%.
During the same period, the number of people dying as a result of the virus has stagnated, with an average of 46.4 Covid-19 patients dying per day. This brings the total number of deaths since the beginning of the pandemic in Belgium to 27,685.
Between 8 and 14 December, an average of 263.3 patients suffering from Covid-19 were admitted to hospitals per day, a 10% decrease since the last seven days.
On Tuesday, a total of 3,258 people were in hospitals due to an infection (124 fewer than on Monday), including 815 patients being treated in intensive care (-23), with 464 on a ventilator (+30).
- Pfizer's anti-Covid pill reduces risk of hospitalisation by almost 90%, study shows
- Belgium supports 9-month limit for EU Covid pass without booster
- Brussels has passed peak of fourth coronavirus wave
The reproduction rate (Rt) remains below one and now sits at 0.93. This figure represents the average number of people infected by each infected person, and when it is lower than 1, it means that the epidemic is slowing down in Belgium.
The incidence, which indicates the number of new cases per 100,000 inhabitants, has decreased by 12% and now sits at 1,814.3 over the past 14 days.
As of Monday, more than 8.74 million people are fully vaccinated, accounting for 88% of the adult population in Belgium, and 76% of the total population.
Meanwhile, more than 2.78 million people have received a booster dose of a coronavirus vaccine, representing 30% of over -18s and 24% of the entire population. The majority of adults should have had the opportunity to get a booster dose by March 2022.